Monness Crespi Hardt upgrades CRM to Buy, citing valuation and AI-driven growth potential after a 42% year-to-date decline.
Monness Crespi Hardt upgraded Salesforce (CRM) to Buy from Neutral, setting a $200 price target and projecting 31% upside. The brokerage highlighted valuation opportunities and AI-related gains as key catalysts.
Salesforce shares have dropped 42% this year and are 58% below their late-2024 peak. The upgrade follows a prolonged downturn in the software sector, with CRM underperforming broader tech indices.
No immediate market reaction was disclosed in the report.